- Home
- PTGX vs ETY Comparison
PTGX vs ETY Comparison
Compare PTGX & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- ETY
- Stock Information
- Founded
- PTGX 2006
- ETY 2006
- Country
- PTGX United States
- ETY United States
- Employees
- PTGX N/A
- ETY N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- ETY Finance Companies
- Sector
- PTGX Health Care
- ETY Finance
- Exchange
- PTGX Nasdaq
- ETY Nasdaq
- Market Cap
- PTGX 2.4B
- ETY 2.4B
- IPO Year
- PTGX 2016
- ETY N/A
- Fundamental
- Price
- PTGX $47.65
- ETY $14.11
- Analyst Decision
- PTGX Strong Buy
- ETY
- Analyst Count
- PTGX 8
- ETY 0
- Target Price
- PTGX $66.50
- ETY N/A
- AVG Volume (30 Days)
- PTGX 1.7M
- ETY 247.3K
- Earning Date
- PTGX 05-06-2025
- ETY 01-01-0001
- Dividend Yield
- PTGX N/A
- ETY 7.21%
- EPS Growth
- PTGX N/A
- ETY N/A
- EPS
- PTGX 4.23
- ETY N/A
- Revenue
- PTGX $434,433,000.00
- ETY N/A
- Revenue This Year
- PTGX N/A
- ETY N/A
- Revenue Next Year
- PTGX $8.12
- ETY N/A
- P/E Ratio
- PTGX $11.56
- ETY N/A
- Revenue Growth
- PTGX 624.05
- ETY N/A
- 52 Week Low
- PTGX $24.22
- ETY $10.59
- 52 Week High
- PTGX $60.60
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- PTGX 53.01
- ETY 33.41
- Support Level
- PTGX $51.06
- ETY $14.33
- Resistance Level
- PTGX $53.70
- ETY $14.78
- Average True Range (ATR)
- PTGX 2.58
- ETY 0.19
- MACD
- PTGX -0.81
- ETY -0.00
- Stochastic Oscillator
- PTGX 0.72
- ETY 23.86
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.